Replimune Group, Inc. 4

Philip Astley-Sparke made a bona fide gift of 50,000 shares of Replimune Group, Inc. common stock to a donor-advised fund.

On August 20, 2026, insider Philip Astley-Sparke reported a bona fide gift of 50,000 shares of Replimune Group, Inc. common stock to a donor-advised fund, recorded as a Code G transaction on Form 4. The transaction price is shown as zero because it is a charitable transfer rather than an open-market trade, and no dollar value can be inferred from the filing due to the absence of price data. Following this gift, Astley-Sparke’s direct ownership stands at 1,362,414 shares of Replimune common stock, indicating that he continues to hold a substantial equity position in the company.

Filing Facts

CIK

1737953

Ticker

REPL

Form

4

Source Type

fda

Accession

0001104659-26-100437

Alert Tier

4